Portfolio of Dividend-Paying Pharmaceutical Stocks

Here are 11 major pharmaceutical companies that pay dividends.


11 Dividend-Paying Pharmaceutical Stocks

Stock Return & Price Chart

Symbol

Dividend (Yield)&
Returns

Recent Dividends

Abbott LaboratoriesABT$1.28 (1.55%)
AbbVieABBV$4.28 (5.24%)
AmgenAMGN$5.80 (2.66%)
AstraZenecaAZN$1.80 (3.72%)
Bristol-Myers SquibbBMY$1.64 (2.87%)
GlaxoSmithKlineGSK$1.83 (4.04%)
Johnson & JohnsonJNJ$3.80 (2.90%)
LillyLLY$2.58 (2.29%)
MerckMRK$2.20 (2.59%)
Novo NordiskNVO$1.80 (3.18%)
PhizerPFE$1.44 (3.75%)
Dividend data from Quandl as of Nov-02-2019.


11 Dividend-Paying Pharmaceutical Stocks

Stock Returns & Price Chart

Symbol

Recent Prices &
Annualized Return

Abbott LaboratoriesABT
AbbVieABBV
AmgenAMGN
AstraZenecaAZN
Bristol-Myers SquibbBMY
GlaxoSmithKlineGSK
Johnson & JohnsonJNJ
LillyLLY
MerckMRK
Novo NordiskNVO
PhizerPFE
Price data from Quandl as of most recent close.


To inspect the performance of the Dividend-Paying Pharmaceutical Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Quandl.

The 10 stocks included in the portfolio computations are: ABT, AMGN, AZN, BMY, GSK, JNJ, LLY, MRK, NVO and PFE. The current value of the portfolio assumes that $1,000.00 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. ABBV was excluded from the portfolio computations because of insufficient price data.

The current value of a $10,000 investment is $209,141. The percent return is 1,991.41%. The annualized return is 27.76%.




Return Summary for Dividend-Paying Pharmaceutical Stocks
Start DateNov-30-2009
Start Investment$5,541.32
End DateNov-20-2019
Current Value of Investment$115,892.03
Total Return1,991.41%
Annualized Return35.53%
Min DateMay-28-2010
Min Price$5,441.59
Max DateNov-20-2019
Max Price$115,892.03
# Values121
Number Returns7,260
Number Profitable Returns6,899
Percent Profitable Returns95.03%
Number Unprofitable Returns361
Percent Unprofitable Returns4.97%
Profitable to Unprofitable Returns Ratio19.11



NOTE: The stocks included in the tables and chart are representative of the industry. They are not recommendations.


Related Portfolios

Portfolio of Biotech Stocks

Portfolio of Generic Drug Stocks